Business

Moderna stock drops by 6.5% after low demand

Moderna Inc shares fell 6.5% on Thursday after the firm disclosed a revenue loss and reduced production of its COVID-19 vaccine, Spikevax, due to decreasing demand. According to The Times, Moderna reported a $3.6 billion loss after taxes in the third quarter of 2023. Its revenue dropped by 46% annually to $1.83 billion, a decline […]